Scilex (SCLX) News Today $0.33 -0.01 (-1.64%) As of 11:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025January 31, 2025 | globenewswire.comScilex (NASDAQ:SCLX) Coverage Initiated at D. Boral CapitalD. Boral Capital began coverage on Scilex in a research report on Monday. They issued a "buy" rating and a $22.00 price target for the company.January 28, 2025 | marketbeat.comScilex (NASDAQ:SCLX) Coverage Initiated by Analysts at D. Boral CapitalD. Boral Capital initiated coverage on Scilex in a research note on Monday. They issued a "buy" rating and a $22.00 price target on the stock.January 27, 2025 | marketbeat.comScilex regains compliance with Nasdaq listing rulesJanuary 21, 2025 | markets.businessinsider.comScilex to file SNDA with FDA for ELYXYBJanuary 21, 2025 | markets.businessinsider.comSCLX Beats on Earnings as Product Line ExpandsJanuary 21, 2025 | msn.comScilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)January 21, 2025 | globenewswire.comScilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025January 21, 2025 | globenewswire.comScilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLCJanuary 21, 2025 | globenewswire.comScilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024January 21, 2025 | globenewswire.comScilex (NASDAQ:SCLX) Announces Earnings ResultsScilex (NASDAQ:SCLX - Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.18) earnings per share (EPS) for the quarter.January 17, 2025 | marketbeat.comScilex amends license agreement with Romeg TherapeuticsJanuary 17, 2025 | markets.businessinsider.comScilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in AdultsJanuary 16, 2025 | globenewswire.comScilex announces Pain Medicine News published data on ZTildo vs Lidocaine 5%January 13, 2025 | markets.businessinsider.comScilex Holding Company Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% PatchJanuary 13, 2025 | markets.businessinsider.comWall Street Futures Gain Pre-Bell Tuesday, Pointing to Higher Open for 2024's Last SessionDecember 31, 2024 | msn.comScilex announces change in record date for dividend of preferred stockDecember 30, 2024 | markets.businessinsider.comScilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from November 7, 2024 to January 28, 2025December 30, 2024 | globenewswire.comScilex Holding (NASDAQ:SCLX) Short Interest Down 14.0% in DecemberScilex Holding (NASDAQ:SCLX - Get Free Report) saw a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 5,280,000 shares, a decrease of 14.0% from the November 30th total of 6,140,000 shares. Approximately 3.3% of the shares of the stock are short sold. Based on an average daily volume of 2,070,000 shares, the short-interest ratio is presently 2.6 days.December 30, 2024 | marketbeat.comWall Street Futures Inch Higher Ahead of Tuesday's Shortened Trading HoursDecember 24, 2024 | msn.comScilex Holding (NASDAQ:SCLX) Insider Acquires $13,800.00 in StockDecember 19, 2024 | insidertrades.comScilex Holding Company Announces Early Repayment of $13.2 Million Under Oramed NoteDecember 18, 2024 | nasdaq.comJaisim Shah Purchases 30,000 Shares of Scilex Holding (NASDAQ:SCLX) StockScilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah bought 30,000 shares of the stock in a transaction on Wednesday, December 18th. The shares were acquired at an average cost of $0.46 per share, for a total transaction of $13,800.00. Following the purchase, the insider now owns 139,333 shares in the company, valued at approximately $64,093.18. This represents a 27.44 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.December 18, 2024 | marketbeat.comAlliance Global Partners Sticks to Their Buy Rating for Scilex Holding Company (SCLX)December 18, 2024 | markets.businessinsider.comScilex Holding Company Announces Closing of $17 Million Registered Direct OfferingDecember 13, 2024 | globenewswire.comScilex dips 8% on $17M direct stock offeringDecember 12, 2024 | msn.comScilex Holding Company Announces $17 Million Registered Direct OfferingDecember 12, 2024 | globenewswire.comScilex Bio says KDS201 currently enrolling with U.S. patient cohort to be addedDecember 11, 2024 | tipranks.comScilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer's Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025December 11, 2024 | globenewswire.comScilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trials Conducted by NeuroBiogen for KDS2010, a Novel Oral Tablet Recently Synthesized Potent, Selective, and Reversible Monoamine Oxidase B inhibitorDecember 11, 2024 | globenewswire.comScilex Holding Company (SCLXW)December 5, 2024 | finance.yahoo.comShort Interest in Scilex Holding (NASDAQ:SCLX) Declines By 51.1%Scilex Holding (NASDAQ:SCLX - Get Free Report) saw a significant decline in short interest in November. As of November 15th, there was short interest totalling 5,400,000 shares, a decline of 51.1% from the October 31st total of 11,040,000 shares. Based on an average daily volume of 1,970,000 shares, the days-to-cover ratio is presently 2.7 days. Currently, 4.2% of the shares of the company are sold short.November 28, 2024 | marketbeat.comScilex Holding Co reaches agreement to waive default penaltiesNovember 24, 2024 | uk.investing.comScilex Holding Company Announces Receipt of Notice from NasdaqNovember 22, 2024 | globenewswire.comScilex Holding Plans Merger to Boost Semnur ValueNovember 6, 2024 | markets.businessinsider.comSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and DenaliNovember 6, 2024 | globenewswire.comPleasing Signs As A Number Of Insiders Buy Scilex Holding StockOctober 30, 2024 | finance.yahoo.comScilex announces successful end of Phase II meeting with FDAOctober 30, 2024 | markets.businessinsider.comScilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4%, a Next-Generation, Triple-Strength Formulation of ZTlido, for the Treatment of Chronic Neck Pain Associated with October 30, 2024 | globenewswire.comJaisim Shah Purchases 32,000 Shares of Scilex Holding (NASDAQ:SCLX) StockOctober 30, 2024 | insidertrades.comJaisim Shah Acquires 32,000 Shares of Scilex Holding (NASDAQ:SCLX) StockScilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah purchased 32,000 shares of the company's stock in a transaction dated Tuesday, October 29th. The stock was purchased at an average cost of $0.99 per share, with a total value of $31,680.00. Following the purchase, the insider now owns 109,333 shares in the company, valued at approximately $108,239.67. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.October 29, 2024 | marketbeat.comScilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common StockOctober 29, 2024 | globenewswire.comScilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned SubsidiaryOctober 28, 2024 | globenewswire.comWhat is HC Wainwright's Forecast for Scilex Q3 Earnings?Scilex Holding (NASDAQ:SCLX - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares of Scilex in a report released on Monday, October 21st. HC Wainwright analyst R. Selvaraju expects that the company will post earnings of ($0October 23, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reiterated a "buy" rating and set a $7.00 price target on shares of Scilex in a report on Monday.October 21, 2024 | marketbeat.comScilex Holding (NASDAQ:SCLX) Director Yue Alexander Wu Acquires 20,000 SharesOctober 21, 2024 | insidertrades.comInsider Buying: Scilex Holding (NASDAQ:SCLX) Insider Acquires 30,000 Shares of StockOctober 18, 2024 | insidertrades.comScilex Holding (NASDAQ:SCLX) Insider Buys $29,700.00 in StockScilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah bought 30,000 shares of the stock in a transaction on Wednesday, October 16th. The stock was acquired at an average price of $0.99 per share, with a total value of $29,700.00. Following the completion of the acquisition, the insider now owns 77,333 shares of the company's stock, valued at $76,559.67. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.October 17, 2024 | marketbeat.comHolding Company Shares Rally Following Board Of Directors CommentaryOctober 16, 2024 | theglobeandmail.comScilex Holding To Explore Ways To Maximize Value Scilex Pharma.October 16, 2024 | markets.businessinsider.com Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address SCLX Media Mentions By Week SCLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCLX News Sentiment▼0.000.60▲Average Medical News Sentiment SCLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCLX Articles This Week▼03▲SCLX Articles Average Week Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FHTX News TSHA News CYRX News ANNX News CRVS News TRVI News CMPS News AQST News GOSS News CADL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCLX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCLX Stock Alerts